Nonviral vector-mediated RNA interference: Its gene silencing characteristics and important factors to achieve RNAi-based gene therapy
Authors:
- Yuki TakahashiYTYuki Takahashi
- Makiya NishikawaMNMakiya Nishikawa
- Yoshinobu TakakuraYTYoshinobu Takakura
- 1 July 2009
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 61 (9) , 760-766
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Biomedical Innovation
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 80 references indexed in Scilit:
- Expression of shRNA From a Tissue-specific pol II Promoter Is an Effective and Safe RNAi TherapeuticMolecular Therapy, 2008
- Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAsRNA, 2008
- Long-Term Suppression of Hepatitis B Virus Replication by Short Hairpin RNA Expression Using the Scaffold/Matrix Attachment Region-Based Replicating Vector System pEPI-1Antimicrobial Agents and Chemotherapy, 2008
- Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAiProceedings of the National Academy of Sciences, 2008
- Sequence- and target-independent angiogenesis suppression by siRNA via TLR3Nature, 2008
- Chemical modification: the key to clinical application of RNA interference?Journal of Clinical Investigation, 2007
- RNAi therapeutics: Principles, prospects and challengesAdvanced Drug Delivery Reviews, 2007
- A versatile approach to multiple gene RNA interference using microRNA-based short hairpin RNAsBMC Molecular Biology, 2007
- Transcriptional and phenotypic comparisons of Ppara knockout and siRNA knockdown miceNucleic Acids Research, 2006
- Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathwaysNature, 2006